Ascentage Pharma Group International logo

Ascentage Pharma Group International

AAPG | NASDAQ
Chart Builder DCF Calculator
$16.17
+$0.31 (+1.95%)
Sep 22, 2026, 2:09 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
2.47B 1.24B 1.07B 1.48B 1.71B 1.02B
Short-Term Investments
n/a n/a n/a n/a n/a n/a
Long-Term Investments
37.05M 33.86M 18.95M 18.53M 27.85M 31.77M
Other Long-Term Assets
30.74M 59M 10.05M 361.93M 35.88M 21.13M
Receivables
253.1M 99.07M 163.54M 61.49M 54.13M 480K
Inventory
28.64M 6.6M 16.17M 9.45M 3.93M n/a
Other Current Assets
192.65M 24.63M 24.54M 16.6M 59.26M 17.31M
Total Current Assets
2.95B 1.47B 1.34B 1.64B 1.89B 1.08B
Property-Plant & Equipment
829.59M 905.86M 957.23M 650.03M 854.3M 477M
Goodwill & Intangibles
90.69M 100.69M 110.14M 109M 85.11M 122.09M
Total Long-Term Assets
1.02B 1.14B 1.16B 1.19B 1.05B 652M
Total Assets
3.97B 2.62B 2.5B 2.83B 2.94B 1.73B
Account Payables
106.81M 91.97M 72.45M 95.56M 70.86M 23.36M
Deferred Revenue
37.51M 54.09M 38.41M 24.35M n/a 6.58K
Short-Term Debt
1.22B 769.62M 606.65M 510.31M 39.8M 44.75M
Other Current Liabilities
276.84M n/a n/a 2.82M 58.73M 16.87M
Total Current Liabilities
1.64B 1.17B 934.17M 881.15M 361.11M 276.15M
Long-Term Debt
742.8M 868.64M 1.17B 1.27B 1.03B 473.06M
Other Long-Term Liabilities
12.04M 6.27M 18.3M 35.33M 52.34M 73.57M
Total Long-Term Liabilities
986.62M 1.18B 1.5B 1.54B 1.34B 608.27M
Total Liabilities
2.63B 2.34B 2.43B 2.42B 1.71B 884.42M
Total Debt
1.98B 1.67B 1.8B 1.79B 1.08B 529.7M
Book Value
1.34B 274.16M 70.63M 408.66M 1.23B 846.62M
Book Value Per Share
15 3.63 4 24.80 77.59 62.74
Common Stock
256.16K 214K 197K 180K 178K 154K
Retained Earnings
n/a -5.77B -5.37B -4.44B -3.56B -2.77B
Comprehensive Income
1.33B -510.59M -504.46M -518.51M -550.95M -509.81M
Shareholders Equity
1.33B 264.19M 60.42M 408.66M 1.23B 846.62M
Total Investments
37.05M 33.86M 18.95M 18.53M 27.85M 31.77M

© 2026 bestshares.com. All rights reserved.